Common Contracts
3 similar Employment Agreement contracts by Flamel Technologies Sa
EMPLOYMENT AGREEMENTEmployment Agreement • May 27th, 2016 • Flamel Technologies Sa • Pharmaceutical preparations • Missouri
THIS EMPLOYMENT AGREEMENT (this "Agreement") is entered into as of the 24th of May, 2016, (the "Effective Date" ), by and among Michael S. Anderson ("Executive"), a citizen of the United States currently residing at 1847 Oxborough Ct., Chesterfield, MO 63017; FLAMEL TECHNOLOGIES SA, a French Societe Anonyme with a principal office located at 33, avenue du Dr. Georges Levy, Parc Club du Moulin à Vent, 69200 Venissieux, France ("Flamel"); and ECLAT PHARMACEUTICALS, LLC, a Delaware limited liability company and affiliate of the Company with a principal office located at 16640 Chesterfield Grove Road, Suite 200, Chesterfield, MO 63005 ("Eclat") together with Flamel (the "Company").
EMPLOYMENT AGREEMENTEmployment Agreement • May 27th, 2016 • Flamel Technologies Sa • Pharmaceutical preparations • Missouri
THIS EMPLOYMENT AGREEMENT (this "Agreement") is entered into as of the 23rd of May, 2016, with the employment to which it pertains beginning on 23rd of November, 2015 (the "Effective Date" ), by and among Michael F. Kanan ("Executive"), a citizen of the United States currently residing at 1572 Highland Valley, Wildwood, MO 63005; FLAMEL TECHNOLOGIES SA, a French Societe Anonyme with a principal office located at 33, avenue du Dr. Georges Levy, Parc Club du Moulin à Vent, 69200 Venissieux, France ("Flamel"); and ECLAT PHARMACEUTICALS, LLC, a Delaware limited liability company and affiliate of the Company with a principal office located at 16640 Chesterfield Grove Road, Suite 200, Chesterfield, MO 63005 ("Eclat") together with Flamel (the "Company").
EMPLOYMENT AGREEMENTEmployment Agreement • March 15th, 2016 • Flamel Technologies Sa • Pharmaceutical preparations • Missouri
THIS EMPLOYMENT AGREEMENT (this "Agreement") is entered into as of the 7th of July, 2015, with the employment to which it pertains beginning on 25th of November, 2013 (the "Effective Date" ), by and among Phillandas T. Thompson ("Executive"), a citizen of the United States currently residing at 16329 Justus Post Road, Chesterfield, MO 63017; FLAMEL TECHNOLOGIES SA, a French Societe Anonyme with a principal office located at 33, avenue du Dr. Georges Levy, Parc Club du Moulin a Vent, 69200 Venissieux, France ("Flamel"); and ECLAT PHARMACEUTICALS, LLC, a Delaware limited liability company and affiliate of the Company with a principal office located at 702 Spirit 40 Park Drive, Suite 108, Chesterfield, MO 63005 ("Eclat") together with Flamel (the "Company").
